A federal judge allowed some of Eli Lilly & Co.‘s claims to proceed that allege a Texas-based compounding pharmacy violated ...

Judges allow consolidation of vision loss lawsuits filed against Novo Nordisk and Eli Lilly over diabetes and weight loss ...

The market is surging due to the rising prevalence of chronic diseases and a massive shift toward home-based ...

A wave of transformative US drug-pricing agreements and record manufacturing investments from leading biopharmaceutical ...

Explore Pfizer Inc.’s 2025-2026 outlook: challenges, flat revenues, patent risks, and potential from the Metsera deal. Click ...

Patients on tirzepatide also experienced more metabolic benefits, such as greater reductions in weight and HbA1c, compared ...

It doesn't have the highest yield, but it has enviable dividend coverage and a long history of surviving in a competitive ...

With a market capitalization approaching the $1 trillion mark, Eli Lilly is engaged in a close competitive race with Novo Nordisk for dominance in the obesity treatment sector. Market researchers ...

My Prescription Costs What?! Pharmacists Offer Tips That Could Reduce Your Out-Of-Pocket Drug Costs. Even when Americans have ...

Eli Lilly and Company has delivered significant positive developments this week, though its shares experienced a minor pullback in Wednesday's trading sessio ...

Market sentiment has visibly soured. Year-to-date, the share price is down approximately 52%, and it has declined nearly 60% over a twelve-month period. The stock is trading close to its 52-week low, ...

BME’s portfolio is a who’s-who of medical-device makers. What’s more, Becton Dickinson is not a top-10 holding (it’s No. 16, ...